Lawsuit Challenging Nexium Ad Claims Dismissed
This article was originally published in The Tan Sheet
Executive Summary
A Wilmington, Del. federal court dismissed a deceptive advertising lawsuit against AstraZeneca after finding that statements made in ads for the heartburn therapy Nexium (esomeprazole) adhered to FDA-approved labeling